Day One Biopharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC DAWN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

124,422

Value ($000)

1,160

Weight

0.0%

2023 Q4 - 2025 Q4 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,160	0.0%	124,422	12/31/2025
2025 Q3	11/14/2025	820	0.0%	116,245	9/30/2025
2025 Q2	8/14/2025	1,140	0.0%	175,416	6/30/2025
2025 Q1	5/19/2025	890	0.0%	112,279	3/31/2025
2024 Q4	2/14/2025	958	0.0%	75,579	12/31/2024
2024 Q3	11/14/2024	908	0.0%	65,193	9/30/2024
2024 Q2	8/14/2024	961	0.0%	69,730	6/30/2024
2024 Q1	5/15/2024	626	0.0%	37,879	3/31/2024
2023 Q4	2/14/2024	209	0.0%	14,300	12/31/2023